Publications by authors named "M I Daneshvar"
Article Synopsis
- - The study developed a nomogram to predict the likelihood of pelvic lymph node metastases (ypN+) after neoadjuvant chemotherapy in nonmetastatic muscle-invasive bladder cancer patients, finding that ypN+ is linked to worse overall survival.
- - Data from 6,194 patients were analyzed, revealing that 22.8% of high-risk patients had ypN+, compared to only 8.0% in the low-risk group, with high-risk patients experiencing significantly shorter survival (36.1 vs. 74.0 months).
- - Key factors contributing to the nomogram included age, time from diagnosis to treatment, and the tumor’s histology and stage, making it a valuable tool for assessing risk
Background: Limited evidence suggested different outcomes of surface treatment methods on zirconia abutments and crowns. Therefore, we investigated the effect of grooving, hot etching, and airborne particle abrasion (APA) methods on zirconia crowns over Ti-base zirconia abutments retention and fracture strength.
Materials And Methods: In this study, 110 zirconia crowns and abutments were divided into five groups, including APA for crown and grooved zirconia abutment (APACr-GrAb), APA for crown and hot etching zirconia abutment (APACr-HtAb), grooved modified zirconia crown and APA for zirconia abutments (GrCr-APAAb), hot etching modified zirconia crown and APA for zirconia abutments (HtCr-APAAb), and APA for both crown and zirconia abutments (control group).
Non-muscle-invasive bladder cancer (NMIBC) is the most common type of bladder cancer presentation and is characterized by a varying probability of recurrence and progression. Sporadically, patients with NMIBC might also develop tumour metastases without any pathological evidence of muscle-invasive disease within the bladder, a condition known as metastatic NMIBC. In the published literature, this phenomenon is limited to several case reports and small reviews, with few data regarding the possible aetiologies.
View Article and Find Full Text PDFArticle Synopsis
- Enfortumab vedotin (EV) and pembrolizumab (P) are standard treatments for advanced urothelial carcinoma, and this study investigates the safety of combining EV with radiation therapy (RT).
- The study involved nine patients who received EV and RT simultaneously, focusing on the side effects of radiation and symptom relief.
- Results showed that adverse effects were mostly mild, with significant symptom relief achieved; further research is suggested for broader conclusions.
Purpose: Young adult Latino testicular cancer survivors experience adverse impacts after treatment. We developed Goal-focused Emotion regulation Therapy (GET) to improve distress symptoms, goal navigation skills, and emotion regulation. This open pilot trial extended GET to Latino young adult survivors of testicular cancer and assessed feasibility and tolerability as well as changes in anxiety and depressive symptoms.
View Article and Find Full Text PDF